Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001193805-17-003506)

Filing Details

Accession Number:: 0001193805-17-003506
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2017-11-16 21:32:21
Reporting Period:: 2017-11-09

Accepted Time:: 2017-11-16 21:32:21
Original Submission Date:: 2017-11-13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368514	Adma Biologics Inc.	ADMA	Biological Products, (No Disgnostic Substances) (2836)	562590442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1708960	Biotest Pharmaceuticals Corp	5800 Park Of Commerce Blvd., Nw Boca Raton FL 63303		Yes	No	Yes	No
1709152	Ag Biotest	Landsteinerstr. 5 Dreieich 2M 63303		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-09	5,813,954	$2.15	10,109,534	No	4	P	Indirect	By Biotest Pharmaceuticals Corporation

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Biotest Pharmaceuticals Corporation

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Non-Voting Common Stock	8,591,160	Indirect	By Biotest Pharmaceuticals Corporation

Footnotes

Represents a purchase from the underwriters in the issuer's public offering.
The shares are owned directly by Biotest Pharmaceuticals Corporation, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG. Biotest AG is a director and a ten percent owner of the issuer.